Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses how community pharmacists can best leverage EHR technology.
The first biosimilar to receive FDA approval is now available the United States.
The first and only patch to provide migraine relief is now available by prescription through specialty pharmacies.
Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, gives counseling points that pharmacists should provide to diabetic patients.
Maine legislators can’t agree on how to address the state’s drug abuse problem.
Use of statins among elderly patients without vascular disease continues to rise despite a lack of evidence demonstrating benefit in this population.
Pregnancy is an important time for women with human immunodeficiency virus (HIV) to receive adequate prenatal care, antiretroviral therapy (ART), and postpartum HIV care to improve clinical outcomes for themselves and their babies.
The FDA has expanded the use of Sunovion’s anticonvulsant eslicarbazepine acetate (Aptiom) as monotherapy for partial-onset seizures.
The 340B Program “mega-guidance” recently released by the Health Resources Services Administration (HRSA) sets stricter standards for contract pharmacy use.
Chris Hatwig, MS, FASHP of Apexus discusses how split billing software helps to keep contract pharmacies organized with respect to 340B requirements.
Chris Hatwig, MS, FASHP of Apexus discusses what HRSA policy updates, including 340B "mega guidance," are poised to affect health-system pharmacists.
If you are receiving radiation and chemotherapy for cancers of the head and neck, you may experience oral mucositis.
Peptic ulcer disease leads to 1 million hospitalizations and 6500 deaths annually.
Dietary supplements are intended to supplement the diet, not to cure, prevent, or treat diseases or replace the variety of foods important to a healthy diet.
Early detection and treatment are key to protecting eyesight.
Strategic Alliance Partners